Home ›
Organizations ›
BIONORTHTEXAS FOUNDATION
BIONORTHTEXAS FOUNDATION
TX · Medical Research · EIN 833860748
2
Executives Disclosed
$1.1M
Annual Revenue
$418K
Total Assets
BIONORTHTEXAS FOUNDATION has 2 executives with disclosed compensation. The highest-paid executive, Kathleen Otto-Rosenblum (CEO), received peak total compensation of $215,525. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Kathleen Otto-Rosenblum | CEO | $216K | $216K | 2023–2024 | 2.9x |
| Kathleen Otto | CEO | $115K | $0 | 2022–2022 | 1.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2022 | 1 | $0 | $0 | $0 |
| 2023 | 1 | $154K | $154K | $154K |
| 2024 | 1 | $216K | $216K | $216K |
Email Alerts
Get notified about BIONORTHTEXAS FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.